Tecovirimat FDA approval date

The FDA approved Tecovirimat (TPOXX) on 13 Jul 2018.

FDA approval date
13 Jul 2018

Drug identity checked against registry records

Also recorded as TPOXX

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOSNCT04957485SIGA TechnologiesPhase 2Active not recruiting2027-01-01Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-07-13DayTecovirimatFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208627", "applicant_as_listed_by_fda": "SIGA TECHNOLOGIES", "brand_names": ["TPOXX"], "active_ingredients": ["TECOVIRIMAT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180713", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026